AI & Machine Learning Acquisitions in New Jersey

Showing 4 transactions.

  • November 10, 2025
    Buyer
    Tradespace
    Target
    Paragon
    Location
    New Jersey, United States
    Type
    Buyout

    Tradespace has acquired Paragon, an AI-driven patent-drafting startup founded by Princeton computer science students, to integrate Paragon’s transparent, traceable patent-drafting technology into its IP management platform. The deal brings Paragon’s founding team into Tradespace and positions Tradespace as an AI-powered platform supporting the full intellectual property lifecycle, accelerating patent drafting and reducing time and cost for corporate, university, and independent inventors.

  • Buyer
    Trivest Partners
    Target
    FROM Digital, Algoworks Solutions
    Location
    New Jersey, United States
    Type
    Addon

    Private equity firm Trivest Partners has completed a merger combining FROM Digital and Algoworks Solutions to form the newly branded Algoworks, an AI-native engineering services and experience-transformation firm. Derek Harrar was appointed CEO to lead the integrated business, which serves large enterprise and Fortune 500 clients across multiple regions.

  • Buyer
    Scutum North America, Scutum Group
    Target
    Visentry
    Location
    New Jersey, United States
    Type
    Addon

    Scutum North America, part of the Scutum Group, has integrated Visentry — an AI-powered remote guarding and video monitoring company based in Englewood, New Jersey — into its U.S. business to expand its technology-enabled security offering. The deal adds Visentry’s AI surveillance and remote response capabilities to Scutum’s 360° security and fire protection portfolio as an add-on to the group’s North America platform.

  • Buyer
    ZS
    Target
    Trials.ai
    Location
    New Jersey, United States
    Type
    Buyout

    Global consulting and technology firm ZS has entered into a definitive agreement to acquire Trials.ai, an AI-powered clinical study design company. The acquisition will integrate Trials.ai's intelligent study-design capabilities into ZS's clinical development offerings to help sponsors identify risks, optimize participant experience and accelerate therapy development timelines.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.